Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

New technique shows promise for therapeutic reversal of food allergies

"This discovery reverses food allergies in mice, and we have many people with allergies volunteering their own cells for us to use in lab testing to move this research forward," said professor John Gordon, lead scientist behind the discovery just published in the current issue of the Journal of Allergy and Clinical Immunology.

27 Oct 2016

Salk researchers develop new computer program to measure blepharosplasm severity

If two clinicians observe the same patient with blepharospasm -- uncontrollable muscle contractions around the eye -- they'll often come away with two different conclusions on the severity of the patient's symptoms.

24 Oct 2016

Oligodendrocytes selectively myelinate specific set of neuronal axons, research shows

There are three kinds of glial cells in the brain, oligodendrocyte, astrocyte and microglia. Oligodendrocytes myelinate neuronal axons to increase conduction velocity of neuronal impulses.

21 Oct 2016

Two leading non-profit organizations sign strategic affiliation to hasten drug development

The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.

20 Oct 2016

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

20 Oct 2016

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

The National Institutes of Health has awarded two co-investigators at Albert Einstein College of Medicine a five-year, $2.6 million grant to make immunotherapy agents that more precisely and effectively treat a variety of cancers while causing far fewer side effects than current immunotherapies.

20 Oct 2016

Exercise may benefit elderly people with memory and thinking problems

Exercise may be associated with a small benefit for elderly people who already have memory and thinking problems, according to new research published in the October 19, 2016, online issue of Neurology, a medical journal of the American Academy of Neurology.

19 Oct 2016

PathMaker Neurosystems receives 2016 Universal Biotech Innovation Prize

PathMaker Neurosystems, a clinical-stage neurotechnology company developing non-invasive neurotherapy systems to treat neuromotor disorders, has been named as the Recipient of the Universal Biotech Innovation Prize 2016 in the global competition that offers "a glimpse of the future of life sciences."

19 Oct 2016

Portsmouth scientist wins major award to develop treatments for MS patients

A University of Portsmouth scientist has won almost £180,000 to fund research that could help develop treatments for multiple sclerosis (MS) patients.

14 Oct 2016

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

Nearly 1,000 boys in the New York Tri-State area have been diagnosed with Duchenne Muscular Dystrophy (DMD) and, until now, had to travel out of the state for comprehensive care.

7 Oct 2016

Adapta Medical receives FDA market clearance for touchless urinary catheter

Adapta Medical, Inc. has received FDA market release for the PerfIC Cath intermittent touchless urinary catheter. The sterile catheter system was designed by J. Glen House, MD, a C7 quadriplegic with limited finger dexterity.

7 Oct 2016

Women may have better verbal memory skills than men during early stages of Alzheimer's disease

Women may have better verbal memory skills than men even when their brains show the same level of problems metabolizing glucose, which occurs in people with Alzheimer's disease, according to research published in the October 5, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology.

5 Oct 2016

Structural instability in myelin membranes may instigate multiple sclerosis

Multiple sclerosis is one of the most devastating neurodegenerative diseases. It affects some 2.5 million people worldwide. It has no known cure.

5 Oct 2016

Scientists find evidence of link between coronavirus and neurological disease

For the first time, researchers have found proof of a direct association between strain OC 43 of the human coronavirus (HCoV) and neurological disease in humans.

3 Oct 2016

Study finds no evidence that exercise may lower woman’s risk of developing MS

A large, new study shows no evidence that exercise may reduce a woman's risk of developing multiple sclerosis (MS).

28 Sep 2016

Hyaluronidase enzyme may be effective treatment option for spasticity caused by neurological injury

A naturally occurring enzyme called hyaluronidase may be an effective alternative treatment for spasticity, or muscle stiffness, a disabling condition in people who have had a stroke or other brain injury.

26 Sep 2016

National Multiple Sclerosis Society calls for change to make MS drugs accessible

When Abigail Bostwick, 36, was diagnosed with multiple sclerosis in 2013, she never thought it would hit her as hard as it has -- not physically -- but financially.

24 Sep 2016

microDimensions to host two compact digital pathology webinars on 11 October, 2016

microDimensions is hosting two compact digital pathology webinars back to back on Oct 11th.

From microDimensions - Bramlage Scientific GmbH 23 Sep 2016

Color-deficiency or color-blindness?

Color blindness could be considered a bit of a misleading term, because there are very few people who can't see color at all. Most people have what we call color deficiency or color confusion, which means that they're not blind to color; they just see a reduced number of colors.

From Vision Express 22 Sep 2016

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology.

21 Sep 2016

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

New technique shows promise for therapeutic reversal of food allergies

Salk researchers develop new computer program to measure blepharosplasm severity

Oligodendrocytes selectively myelinate specific set of neuronal axons, research shows

Two leading non-profit organizations sign strategic affiliation to hasten drug development

TUM scientists uncover novel mechanisms of action for skin disease medication

Einstein researchers awarded $2.6 million NIH grant to develop effective cancer immunotherapies

Exercise may benefit elderly people with memory and thinking problems

PathMaker Neurosystems receives 2016 Universal Biotech Innovation Prize

Portsmouth scientist wins major award to develop treatments for MS patients

First comprehensive center opened in Tri-State area to mark new era in care of DMD patients

Adapta Medical receives FDA market clearance for touchless urinary catheter

Women may have better verbal memory skills than men during early stages of Alzheimer's disease

Structural instability in myelin membranes may instigate multiple sclerosis

Scientists find evidence of link between coronavirus and neurological disease

Study finds no evidence that exercise may lower woman’s risk of developing MS

Hyaluronidase enzyme may be effective treatment option for spasticity caused by neurological injury

National Multiple Sclerosis Society calls for change to make MS drugs accessible

microDimensions to host two compact digital pathology webinars on 11 October, 2016

Color-deficiency or color-blindness?

Experimental drug may prevent development of multiple sclerosis in mice

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in